256. Muscle glycogenosis Clinical trials / Disease details
Clinical trials : 180 / Drugs : 133 - (DrugBank : 29) / Drug target genes : 25 - Drug target pathways : 105
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04044508 (ClinicalTrials.gov) | August 3, 2019 | 12/12/2018 | Modified Ketogenic Diet in Patients With McArdle Disease Part B | Odified Ketogenic Diet in Patients With McArdle Disease Part B - a Placebo-controlled, Cross-over Study | McArdle Disease | Dietary Supplement: Ketocal 4:1 liquid Nutricia (intervention);Dietary Supplement: Fortini multifibre Nutrica (placebo) | Rigshospitalet, Denmark | University College, London | Completed | 18 Years | 80 Years | All | 20 | N/A | Denmark;United Kingdom |